tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PYPD Stock Latest News

PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
Company AnnouncementsPolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
5d ago
6K
PYPD
PolyPid appoints Story as Chairman of Board of Directors
PremiumThe Fly
PolyPid appoints Story as Chairman of Board of Directors
5d ago
PYPD
Roth Capital healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Roth Capital healthcare analyst holds an analyst/industry conference call
16d ago
BDX
JNJ
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
PremiumCompany Announcements
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
18d ago
6K
PYPD
PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
PremiumThe Fly
PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
18d ago
PYPD
PolyPid Expands Share Offering to Strengthen Financial Position
PremiumCompany AnnouncementsPolyPid Expands Share Offering to Strengthen Financial Position
25d ago
6K
PYPD
PolyPid price target lowered to $9 from $10 at Roth Capital
Premium
The Fly
PolyPid price target lowered to $9 from $10 at Roth Capital
1M ago
PYPD
PolyPid Ltd. Advances Towards Key Milestones in 2025
Premium
Company Announcements
PolyPid Ltd. Advances Towards Key Milestones in 2025
1M ago
PYPD
PolyPid Ltd. Earnings Call: Progress and Potential
PremiumCompany Announcements
PolyPid Ltd. Earnings Call: Progress and Potential
1M ago
PYPD
PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline
PremiumRatings
PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline
1M ago
PYPD
PolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness
PremiumCompany Announcements
PolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness
1M ago
6K
PYPD
PolyPid sees cash runway ‘well into’ 2026
PremiumThe Fly
PolyPid sees cash runway ‘well into’ 2026
1M ago
PYPD
PolyPid reports Q3 EPS (37c), consensus (52c)
PremiumThe FlyPolyPid reports Q3 EPS (37c), consensus (52c)
1M ago
PYPD
PYPD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PYPD Upcoming Earnings Report: What to Expect?
1M ago
PYPD
PolyPid Completes Key GMP Inspection for D-PLEX100 Manufacturing Readiness
Premium
Company Announcements
PolyPid Completes Key GMP Inspection for D-PLEX100 Manufacturing Readiness
3M ago
6K
PYPD
PolyPid completes Israeli Ministry of Health GMP inspection
PremiumThe Fly
PolyPid completes Israeli Ministry of Health GMP inspection
3M ago
PYPD
PolyPid Ltd. Earnings Call: Positive Trials and Financial Strength
PremiumCompany Announcements
PolyPid Ltd. Earnings Call: Positive Trials and Financial Strength
4M ago
PYPD
PolyPid price target lowered to $13 from $15 at Craig-Hallum
PremiumThe Fly
PolyPid price target lowered to $13 from $15 at Craig-Hallum
4M ago
PYPD
PolyPid price target raised to $10 from $9 at Roth Capital
PremiumThe Fly
PolyPid price target raised to $10 from $9 at Roth Capital
4M ago
PYPD
PolyPid Reports Strong Phase 3 Results and Financial Update
PremiumCompany AnnouncementsPolyPid Reports Strong Phase 3 Results and Financial Update
4M ago
PYPD
PolyPid Releases Mid-2025 Financial Update
Premium
Company Announcements
PolyPid Releases Mid-2025 Financial Update
4M ago
6K
PYPD
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
Premium
Ratings
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
4M ago
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >